Tradestie Institutional Equity Comparison Engine
CDT vs ACON โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ACON Overall Edge
ACON Captures Institutional Edge (2โ1 Pillars ยท 3โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Aclarion, Inc. Common Stock (ACON) driven by superior Momentum & Technical, Options & Structure while CDT counters with relative strength in Growth & Margin. Fundamentally, CDT trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus ACON at N/M Forward P/E and -10789.2% operating margin (+78.1% YoY). In options structure, CDT sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro) against ACON sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
CDT N/M vs ACON N/M Fwd P/E
Growth & Margin Winner
CDT
Op Margin 0.0% vs -10789.2% ยท YoY +0.0% vs +78.1%
Momentum & Technical Winner
ACON
1Y -86.8% vs -79.2% ยท 52W Pos 2% vs 0%
Options & Structure Winner
ACON
BREAKDOWN (N/A IV) vs UNCLASSIFIED (N/A IV)
CDT
NASDAQ
CDT Equity Inc. Common Stock
Pharmaceutical Preparations
$0.23
-13.89% 1D
Market Cap
$507,528
1M Return
+76.79%
1Y Return
-86.78%
Forward P/E
N/M
Unified AI Score
31.6 / 100
SELL
Tech 15.0
Fund 37.0
Flow 50.0
Mom 54.0
ACON
NASDAQ
Aclarion, Inc. Common Stock
Services-Medical Laboratories
$1.22
-13.92% 1D
Market Cap
$3.7M
1M Return
-36.83%
1Y Return
-79.18%
Forward P/E
N/M
Unified AI Score
42.2 / 100
HOLD
Tech 30.0
Fund 55.0
Flow 50.0
Mom 59.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
CDT -86.78%
ACON -79.18%
Spread: +7.6 pp (ACON Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
CDT TTM Op. Margin: 0.0%
ACON TTM Op. Margin: -10789.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CDT vs ACON. Trailing 12-month operating profitability (CDT 0.0% vs ACON -10789.2%) and valuation multiples (CDT N/M vs ACON N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CDT | ACON | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $507,528 | $3.7M | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | +78.1% | Higher Growth | ACON |
| Operating Margin (TTM) Profitability | 0.0% | -10789.2% | Higher Margin | CDT |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -69.7% | -74.1% | Higher ROE | CDT |
| 52-Week Range Position Momentum | 2% ($0โ$11) | 0% ($1โ$9) | Stronger Trend | CDT |
| Beta / 30D Volatility Risk Regime | -17.75ฮฒ ยท 10175% Vol | 1.36ฮฒ ยท 87% Vol | Lower Realized Risk | ACON |
| Unified Institutional Score Composite Signal | 31.6 / 100 (SELL) | 42.2 / 100 (HOLD) | Higher Composite | ACON |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full CDT vs ACON Buy Guide
CDT
BREAKDOWN
163d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
ACON
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither CDT nor ACON registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.